NO20054002L - Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom - Google Patents

Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom

Info

Publication number
NO20054002L
NO20054002L NO20054002A NO20054002A NO20054002L NO 20054002 L NO20054002 L NO 20054002L NO 20054002 A NO20054002 A NO 20054002A NO 20054002 A NO20054002 A NO 20054002A NO 20054002 L NO20054002 L NO 20054002L
Authority
NO
Norway
Prior art keywords
diarrhea
treatment
bowel syndrome
irritable bowel
predominantly
Prior art date
Application number
NO20054002A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054002D0 (no
Inventor
Akito Nishida
Akira Niwa
Yutaka Atsuta
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2004/000896 external-priority patent/WO2004066998A1/ja
Priority claimed from PCT/JP2004/006657 external-priority patent/WO2005073220A1/ja
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO20054002D0 publication Critical patent/NO20054002D0/no
Publication of NO20054002L publication Critical patent/NO20054002L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20054002A 2004-01-30 2005-08-29 Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom NO20054002L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/JP2004/000896 WO2004066998A1 (ja) 2003-01-31 2004-01-30 安定な経口用固形医薬組成物
PCT/JP2004/006657 WO2005073220A1 (ja) 2004-01-30 2004-05-12 下痢型過敏性腸症候群治療剤
PCT/JP2005/001549 WO2005072730A1 (ja) 2004-01-30 2005-01-27 下痢型過敏性腸症候群治療剤

Publications (2)

Publication Number Publication Date
NO20054002D0 NO20054002D0 (no) 2005-08-29
NO20054002L true NO20054002L (no) 2005-10-26

Family

ID=34829390

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054002A NO20054002L (no) 2004-01-30 2005-08-29 Behandlingsmiddel for diar±-predominant irritabel tarmsyndrom

Country Status (11)

Country Link
EP (1) EP1559446B1 (pt)
AT (1) ATE516061T1 (pt)
AU (1) AU2005209112B2 (pt)
BR (1) BRPI0503488A (pt)
CA (1) CA2516433C (pt)
MX (1) MXPA05009025A (pt)
NO (1) NO20054002L (pt)
NZ (1) NZ541656A (pt)
PL (1) PL380448A1 (pt)
RU (1) RU2314808C2 (pt)
WO (1) WO2005072730A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381422B1 (en) * 1989-02-02 1996-10-23 Yamanouchi Pharmaceutical Co. Ltd. Tetrahydrobenzimidazole derivatives
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
WO1999064401A2 (en) * 1998-06-12 1999-12-16 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Imidazolyl derivatives and their use as somatostatin receptor ligands
AR028970A1 (es) * 2000-07-26 2003-05-28 Solvay Pharm Gmbh USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE
US6566369B2 (en) * 2000-07-26 2003-05-20 Solvay Pharmaceuticals Gmbh Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients

Also Published As

Publication number Publication date
BRPI0503488A (pt) 2006-03-07
EP1559446B1 (en) 2011-07-13
NZ541656A (en) 2008-05-30
MXPA05009025A (es) 2006-04-27
RU2314808C2 (ru) 2008-01-20
RU2005127333A (ru) 2006-07-10
CA2516433A1 (en) 2005-08-11
AU2005209112A1 (en) 2005-08-11
ATE516061T1 (de) 2011-07-15
WO2005072730A1 (ja) 2005-08-11
HK1090561A1 (zh) 2006-12-29
AU2005209112B2 (en) 2007-07-05
EP1559446A1 (en) 2005-08-03
NO20054002D0 (no) 2005-08-29
PL380448A1 (pl) 2007-02-05
CA2516433C (en) 2009-06-02

Similar Documents

Publication Publication Date Title
EP2248519A3 (en) Non-mucoadhesive film dosage forms
MX2025001619A (es) Inhibidor de pde4b y uso del mismo
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
CY1124914T1 (el) Στερεες φαρμακευτικες συνθεσεις που περιεχουν αναστολεα ιντεγκρασης
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
ECSP077387A (es) Composiciones que contienen piperacilina, tazobactam y un ácido aminocarboxílico en un diluyente de lactato de sodio
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
WO2021168483A3 (en) Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
NO20080244L (no) Doseringsstyring for prasugrel
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
RU2003104798A (ru) Содержащие циланзетрон лекарственные средства для лечения не страдающих запорами пациентов мужского пола с синдромом раздраженного кишечника (срк)
ES2299738T3 (es) Composicion farmaceutica que combina el tenatoprazol y un antagonista de los receptores h2 a la histamina.
AR066667A1 (es) Composiciones farmaceuticas que comrenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg coa reductasa
SG146631A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
BRPI0503488A (pt) agente de tratamento para sìndrome de intestino irritável com diarréia predominante
NO20044900L (no) Progestagene doseringsenheter
RU2023121182A (ru) Применение 1-(2-(1н-имидазол-4-ил)этил)пиперидин-2,6-диона для лечения кашля, вызванного вирусными инфекциями
MX2024001230A (es) Anticoncepcion oral con progestageno solo.
NZ782935A (en) Treatments of hereditary angioedema
AR051745A1 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyeccion
RU2394581C3 (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application